Experimental therapy of filovirus infections

[1] INTERFERON INDUCTION BY GLYCYRRHIZIN AND GLYCYRRHETINIC ACID IN MICE [J]. MICROBIOLOGY AND IMMUNOLOGY, 1982, 26 (06) : 535 - 539

[2] Chemistry and biochemistry of 2′,5′-oligoadenylate-based antisense strategy [J]. CURRENT MEDICINAL CHEMISTRY, 2001, 8 (10) : 1189 - 1212

[3] ANTIVIRAL IMMUNOTOXINS - ANTIBODY-MEDIATED DELIVERY OF GELONIN INHIBITS PICHINDE VIRUS-REPLICATION INVITRO [J]. ANTIVIRAL RESEARCH, 1991, 15 (02) : 125 - 138

[4] The Ebola virus VP35 protein functions as a type IIFN antagonist [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12289 - 12294

[5] THE ASIALOGLYCOPROTEIN RECEPTOR IS A POTENTIAL LIVER-SPECIFIC RECEPTOR FOR MARBURG VIRUS [J]. JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 393 - 399

[6] Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAART [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11511 - 11513

[7] Borisevich IV, 1995, VOP VIRUSOL+, V40, P270

[8] Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1521 - 1530

[9] A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) : 651 - 661

[10] Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2001, 125 (04) : 243 - 253

[1] INTERFERON INDUCTION BY GLYCYRRHIZIN AND GLYCYRRHETINIC ACID IN MICE [J]. MICROBIOLOGY AND IMMUNOLOGY, 1982, 26 (06) : 535 - 539

[2] Chemistry and biochemistry of 2′,5′-oligoadenylate-based antisense strategy [J]. CURRENT MEDICINAL CHEMISTRY, 2001, 8 (10) : 1189 - 1212

[3] ANTIVIRAL IMMUNOTOXINS - ANTIBODY-MEDIATED DELIVERY OF GELONIN INHIBITS PICHINDE VIRUS-REPLICATION INVITRO [J]. ANTIVIRAL RESEARCH, 1991, 15 (02) : 125 - 138

[4] The Ebola virus VP35 protein functions as a type IIFN antagonist [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12289 - 12294

[5] THE ASIALOGLYCOPROTEIN RECEPTOR IS A POTENTIAL LIVER-SPECIFIC RECEPTOR FOR MARBURG VIRUS [J]. JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 393 - 399

[6] Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAART [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11511 - 11513

[7] Borisevich IV, 1995, VOP VIRUSOL+, V40, P270

[8] Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1521 - 1530

[9] A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) : 651 - 661

[10] Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2001, 125 (04) : 243 - 253